Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 394 (NASDAQ: NEPT) (TSX: NEPT) (TSXV: RLV) (TSX: WEED) (NYSE: CGC)
Delta, Kelowna, BC - April 3, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, #Cannabis News and #Stocks on the Move; Episode 394 (NASDAQ: $NEPT) (TSX: NEPT) (TSX.V: RLV) (TSX: WEED) (NYSE: $CGC)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today's podcast we are looking at a few public announcements.
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) announced that it has received Health Canada authorization to commercialize natural, plant-based hand sanitizer products. The Company has also engaged with the National Research Council of Canada (NRC), Canada's largest federal research and development organization, to support NRC's efforts to facilitate the development, manufacturing and ultimately commercialization of solutions to meet COVID-19 related needs.
Neptune will leverage its product formulation expertise to develop natural, plant-based sanitizers that effectively kills 99.9% of germs and bacteria, made with a specialized blend of essential oils and fruit extract. The product will be formulated at the Company's production and processing facilities in Sherbrooke, Quebec and Conover, North Carolina, and also with the help of its contract manufacturing partners.
Following its assessment of Neptune's plant-based hand sanitizer products, deeming it as safe and effective in killing bacteria and germs and of high quality, Health Canada issued Neptune a product license and Natural Product Number (NPN), which will appear on the product label to inform customers that the product has been reviewed and approved by Health Canada.
In an effort to supply the North American demand of hand sanitizer products, the Company is also working to fast track FDA registration to produce and market OTC hand sanitizer formulations and products out of its Conover, North Carolina facility.
Neptune is currently sourcing new supply of raw material inputs to ensure ample product supply at launch, which is expected in Summer 2020. Neptune intends to sell its hand sanitizer formulations to consumer-packaged goods (CPG) brands as well as retailers seeking private label owned brands to offer to their customers in the U.S. and Canada. The Company also plans to supply the U.S. and Canadian governments and healthcare systems with sanitizer products through both direct and indirect channels.
"We are very pleased to receive Health Canada authorization to bring our plant-based hand sanitizer to market as we believe consumers will increasingly look for natural sanitizers as their use of these products become more regular in light of COVID-19," said Michael Cammarata, Chief Executive Officer of Neptune. "Neptune's entrance into the hand sanitizer market reflects our ability to be nimble and quickly meet strong market demand for effective, natural and safe household health and wellness products. Our procurement and sales teams are working in concert with our scientists and engineers to source high quality raw materials in order to ramp up production and bring our products to market as quickly as possible."
Relevium is leveraging its strong network of suppliers and formulators to manufacture and bring to market a line of hand sanitizers under the Bioganix ® Cleancare. The Company will have an initial format of 8oz (235ml) that will effectively kill 99.9% of germs and bacteria. The product is formulated and manufactured in Miami, Florida at the Company's specialty products contract manufacturing partner and will be sold both online and through selected retail chains in the US.
Relevium expect to receive its first production batch in about 8 weeks
"The impact of the COVID-19 pandemic will go beyond the immediate socio-economic state of emergency and we believe we will see the rise of new social interaction practices, which will become the norm. We are pleased to position Bioganix® Cleancare as part of this new norm and become a household must amongst our current and future customers" said Aurelio Useche, Chief Executive Officer of Relevium.
Storz & Bickel announced that Health Canada has issued a Medical Device Licence for the new Volcano Medic 2 (License No.: 103842), an advanced cannabis vapourizer device for medical use. This licence permits distribution to medical institutions, clinics, and patients in Canada - including distribution through Spectrum Therapeutics, the medical cannabis division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC). The device is currently available for purchase on Spectrum Therapeutics, Storz & Bickel's online shop, and various medical cannabis clinics across Canada.
Storz & Bickel is known for their long history of high quality vapourizer manufacturing and they were the first company to manufacture medically-certified cannabis vapourizers, including the iconic original Volcano Medic.
The Volcano Medic 2, which has been approved for medical use in Europe, Australia, and now Canada, includes improved features for patients such as tenfold faster heat up times, an alternative tubular (direct-to-mouth) inhalation method in addition to the standard Valve Balloon, and an intuitive touch display that allows patients to set their desired temperature directly on the device. Patients can expect the same high-quality materials, impeccable craftsmanship, and unparalleled safe and combustion-free vaporization experience they've become accustomed to with all Storz & Bickel devices with the new reinvented Volcano Medic 2. Alongside their medically approved cannabis vapourizers, Storz & Bickel is known for manufacturing non-medical vapourizers in accordance with international technical safety standards, ensuring premium quality for each component part.
Due to its classification as a licensed medical device, the Volcano Medic 2 is eligible for tax deduction benefits in Canada or cost reimbursements by health insurance companies in Germany, similar to its predecessor and the Mighty Medic.
"Storz and Bickel is internationally-known for its best-in-class device design and manufacturing," said Dr. Mark Ware, Chief Medical Officer, Canopy Growth. "This license will allow us to offer even more options for patients who may be interested in vapourizing whole-flower dried cannabis as an alternative method of medicating."
In the past 12 months, Storz & Bickel updated several products in their existing portfolio, adding new features, improvements, and adjustments designed to increase user and patient experience, including the new Volcano Hybrid that was released in June and the Crafty+ that launched in November.
Senators in Mexico asked the Supreme Court March 27 to extend an April 30 deadline for lawmakers to draft a bill to legalize and regulate cannabis for medical, adult and industrial uses, according to a Cannabis Wire report.
The legislation has been stalled since three Senate committees approved the legislation last month.
Both the Senate and the Supreme Court have suspended many legislative procedures until at least mid-April due to the COVID-19 outbreak, Cannabis Wire reported, and many lawmakers have indicated that this will cause them to miss deadlines to pass certain bills, including the cannabis legislation.
Sen. Patricia Mercado told Cannabis Wire that the suspension of the Supreme Court will likely mean a deadline extension on the cannabis bill, and said the deadline should be extended to May 30 to align with how long Supreme Court activities are suspended.
However, she added there may be a chance that the Supreme Court could deem the Senate as an essential activity and mandate that lawmakers must meet the April 30 deadline.
In that case, Mercado told Cannabis Wire that the senators would hold electronic meetings to finalize the bill, which would then be sent to the Chamber of Deputies, Mexico's lower house of Congress, for approval.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android